Fadime Dogan

781 total citations
29 papers, 614 citations indexed

About

Fadime Dogan is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Epidemiology. According to data from OpenAlex, Fadime Dogan has authored 29 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Fadime Dogan's work include Neuroendocrine Tumor Research Advances (10 papers), Pituitary Gland Disorders and Treatments (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Fadime Dogan is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), Pituitary Gland Disorders and Treatments (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Fadime Dogan collaborates with scholars based in Netherlands, Italy and United Kingdom. Fadime Dogan's co-authors include Leo J. Hofland, Peter M. van Koetsveld, Wouter W. de Herder, Richard A. Feelders, Steven W. J. Lamberts, Federico Gatto, Diego Ferone, Johan M. Kros, Sebastian Neggers and Marc Peeters and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and British Journal of Cancer.

In The Last Decade

Fadime Dogan

28 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fadime Dogan Netherlands 13 266 259 194 128 127 29 614
Mijke Buitinga Netherlands 15 124 0.5× 138 0.5× 155 0.8× 149 1.2× 54 0.4× 37 647
Sweta Sudhir United States 8 79 0.3× 99 0.4× 83 0.4× 134 1.0× 38 0.3× 16 373
Hirotake Komatsu United States 14 42 0.2× 194 0.7× 193 1.0× 154 1.2× 42 0.3× 48 735
Daniela Kodetová Czechia 12 95 0.4× 186 0.7× 361 1.9× 256 2.0× 15 0.1× 35 779
Carla Pecchioni Italy 10 141 0.5× 159 0.6× 105 0.5× 107 0.8× 67 0.5× 12 384
Natalie Seiser United States 9 113 0.4× 129 0.5× 94 0.5× 189 1.5× 7 0.1× 11 578
Yuki Katsuya Japan 11 25 0.1× 280 1.1× 69 0.4× 62 0.5× 221 1.7× 35 525
Austin Thiel United States 7 154 0.6× 154 0.6× 14 0.1× 450 3.5× 97 0.8× 7 722
Hongfeng Yuan China 14 40 0.2× 116 0.4× 39 0.2× 389 3.0× 19 0.1× 26 649

Countries citing papers authored by Fadime Dogan

Since Specialization
Citations

This map shows the geographic impact of Fadime Dogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadime Dogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadime Dogan more than expected).

Fields of papers citing papers by Fadime Dogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fadime Dogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadime Dogan. The network helps show where Fadime Dogan may publish in the future.

Co-authorship network of co-authors of Fadime Dogan

This figure shows the co-authorship network connecting the top 25 collaborators of Fadime Dogan. A scholar is included among the top collaborators of Fadime Dogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fadime Dogan. Fadime Dogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pas, Rob van der, Peter M. van Koetsveld, Fadime Dogan, et al.. (2025). A Prospective Trial With Ketoconazole Induction Therapy and Octreotide Maintenance Treatment for Cushing's Disease. Journal of the Endocrine Society. 9(7). bvaf089–bvaf089. 2 indexed citations
2.
Mehta, Sonal, Richard A. Feelders, Fadime Dogan, et al.. (2025). Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas?. Pituitary. 28(6). 123–123.
3.
Feelders, Richard A., Fadime Dogan, Peter M. van Koetsveld, et al.. (2023). The Role of the IGF2 Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue. Biomedicines. 11(7). 2013–2013. 1 indexed citations
4.
Refardt, Julie, Peter M. van Koetsveld, Simone U. Dalm, et al.. (2023). Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors. Frontiers in Endocrinology. 14. 1184436–1184436. 4 indexed citations
5.
Koetsveld, Peter M. van, et al.. (2022). The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation. Biomedicines. 10(3). 517–517. 11 indexed citations
6.
Gatto, Federico, Richard A. Feelders, Peter M. van Koetsveld, et al.. (2022). Dissecting the In Vitro Efficacy of Octreotide and Cabergoline in GH- and GH/PRL-Secreting Pituitary Tumors. The Journal of Clinical Endocrinology & Metabolism. 108(5). e98–e109. 4 indexed citations
7.
Cuny, Thomas, Peter M. van Koetsveld, Fadime Dogan, et al.. (2022). Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment. Cancers. 14(14). 3481–3481. 4 indexed citations
8.
Berk, Şeyda, J. A. M. J. L. Janssen, Peter M. van Koetsveld, et al.. (2021). Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer Cells. Frontiers in Oncology. 11. 645732–645732. 5 indexed citations
9.
Dalm, Simone U., et al.. (2021). Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [111In]In-DOTATATE Uptake in NET Cells. Cancers. 13(19). 4905–4905. 11 indexed citations
10.
Koetsveld, Peter M. van, et al.. (2020). Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer. BMC Cancer. 20(1). 913–913. 13 indexed citations
11.
Gatto, Federico, Richard A. Feelders, Rob van der Pas, et al.. (2020). β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids. Journal of Endocrinology. 245(1). 101–113. 4 indexed citations
12.
Martino, Maria Cristina De, Peter M. van Koetsveld, Richard A. Feelders, et al.. (2019). IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer. Endocrine. 64(3). 673–684. 27 indexed citations
13.
Herrera‐Martínez, Aura D., Richard A. Feelders, Wouter W. de Herder, et al.. (2019). Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells. Hormones and Cancer. 10(2-3). 107–119. 12 indexed citations
14.
Hofland, Leo J., et al.. (2019). Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line. Frontiers in Endocrinology. 10. 682–682. 72 indexed citations
15.
Gatto, Federico, Richard A. Feelders, Peter M. van Koetsveld, et al.. (2017). In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas. The Journal of Clinical Endocrinology & Metabolism. 102(6). 2009–2018. 56 indexed citations
16.
Vandamme, Timon, Matthias Beyens, Ken Op de Beeck, et al.. (2016). Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors. British Journal of Cancer. 114(6). 650–658. 63 indexed citations
17.
Gatto, Federico, Nienke R. Biermasz, Richard A. Feelders, et al.. (2016). Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly. European Journal of Endocrinology. 174(5). 651–662. 44 indexed citations
18.
Vandamme, Timon, Marc Peeters, Fadime Dogan, et al.. (2015). Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1. Journal of Molecular Endocrinology. 54(2). 137–147. 78 indexed citations
19.
Biermann, Katharina, Joël Shapiro, Fadime Dogan, et al.. (2015). Absence or low IGF‐1R‐expression in esophageal adenocarcinoma is associated with tumor invasiveness and radicality of surgical resection. Journal of Surgical Oncology. 111(8). 1047–1053. 5 indexed citations
20.
Martino, Maria Cristina De, Richard A. Feelders, Wouter W. de Herder, et al.. (2014). Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors. Endocrine Related Cancer. 21(4). 601–613. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mijke Buitinga Breakdown of academic impact, for papers by Sweta Sudhir Breakdown of academic impact, for papers by Hirotake Komatsu Breakdown of academic impact, for papers by Daniela Kodetová Breakdown of academic impact, for papers by Carla Pecchioni Breakdown of academic impact, for papers by Natalie Seiser Breakdown of academic impact, for papers by Yuki Katsuya Breakdown of academic impact, for papers by Austin Thiel Breakdown of academic impact, for papers by Hongfeng Yuan
Rankless by CCL
2026